Search

Search results

912 results found

Cardiovascular and Limb Events Following Endovascular Revascularization Among Patients ≥65 Years Old: An American College of Cardiology PVI Registry Analysis.

Weissler, Hope, Yongfei Wang, Jordan M Gales, Dmitriy N Feldman, Shipra Arya, Eric A Secemsky, Herbert D Aronow, et al. 2022. “Cardiovascular and Limb Events Following Endovascular Revascularization Among Patients ≥65 Years Old: An American College of Cardiology PVI Registry Analysis.”. Journal of the American Heart Association 11 (12): e024279.

Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study.

Mihatov, Nino, Eric A Secemsky, Dean J Kereiakes, Gabriel Steg, Donald E Cutlip, Ajay J Kirtane, Roxana Mehran, et al. 2022. “Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study.”. Cardiovascular Revascularization Medicine : Including Molecular Interventions 41: 105-12.

Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.

Jovin, Ion S, Rachit M Shah, Dhavalkumar B Patel, Sunil Rao V, Dmitri Baklanov V, Issam Moussa, Kevin F Kennedy, et al. 2017. “Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.”. JACC. Cardiovascular Interventions 10 (11): 1102-11.